Home » Nalmefene North-American Rights Acquired by Lundbeck
Nalmefene North-American Rights Acquired by Lundbeck
Lundbeck has acquired the North-American and Mexican rights for nalmefene from Somaxon Pharmaceuticals.
TradingMarkets
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May